These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12050566)

  • 1. Expression, localization and activity of neutral endopeptidase in cultured cells of benign prostatic hyperplasia and prostate cancer.
    Albrecht M; Gillen S; Wilhelm B; Doroszewicz J; Aumüller G
    J Urol; 2002 Jul; 168(1):336-42. PubMed ID: 12050566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
    Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
    Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
    Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
    Freedland SJ; Seligson DB; Liu AY; Pantuck AJ; Paik SH; Horvath S; Wieder JA; Zisman A; Nguyen D; Tso CL; Palotie AV; Belldegrun AS
    Prostate; 2003 Apr; 55(1):71-80. PubMed ID: 12640663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma.
    Chandler JD; Williams ED; Slavin JL; Best JD; Rogers S
    Cancer; 2003 Apr; 97(8):2035-42. PubMed ID: 12673735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
    Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
    Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
    Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
    Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha(2) macroglobulin, a PSA binding protein, is expressed in human prostate stroma.
    Lin VK; Wang SY; Boetticher NC; Vazquez DV; Saboorian H; McConnell JD; Roehrborn CG
    Prostate; 2005 May; 63(3):299-308. PubMed ID: 15611997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
    Hu XY; Xu YM; Chen XC; Ping H; Chen ZH; Zeng FQ
    APMIS; 2006 Dec; 114(12):893-8. PubMed ID: 17207090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines.
    Dizeyi N; Bjartell A; Nilsson E; Hansson J; Gadaleanu V; Cross N; Abrahamsson PA
    Prostate; 2004 May; 59(3):328-36. PubMed ID: 15042609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia.
    Mannowetz N; Würdinger R; Zippel A; Aumüller G; Wennemuth G
    Prostate; 2010 Sep; 70(12):1350-8. PubMed ID: 20623639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2.
    Wu Q; Zhou Y; Chen L; Shi J; Wang CY; Miao L; Klocker H; Park I; Lee C; Zhang J
    J Endocrinol; 2007 Oct; 195(1):89-94. PubMed ID: 17911400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner.
    Wu Q; Shi J; Chen L; Wang CY; Park I; Lee C; Zhang J
    BJU Int; 2008 Feb; 101(4):497-502. PubMed ID: 18190643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and cellular localization of follicle-stimulating hormone receptor in normal human prostate, benign prostatic hyperplasia and prostate cancer.
    Mariani S; Salvatori L; Basciani S; Arizzi M; Franco G; Petrangeli E; Spera G; Gnessi L
    J Urol; 2006 Jun; 175(6):2072-7; discussion 2077. PubMed ID: 16697805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.
    Fung KM; Samara EN; Wong C; Metwalli A; Krlin R; Bane B; Liu CZ; Yang JT; Pitha JV; Culkin DJ; Kropp BP; Penning TM; Lin HK
    Endocr Relat Cancer; 2006 Mar; 13(1):169-80. PubMed ID: 16601286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression.
    Royuela M; de Miguel MP; Ruiz A; Fraile B; Arenas MI; Romo E; Paniagua R
    Eur Cytokine Netw; 2000 Mar; 11(1):119-27. PubMed ID: 10705309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen.
    Ho CK; Nanda J; Chapman KE; Habib FK
    J Endocrinol; 2008 Jun; 197(3):483-91. PubMed ID: 18492814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells.
    Dai J; Shen R; Sumitomo M; Goldberg JS; Geng Y; Navarro D; Xu S; Koutcher JA; Garzotto M; Powell CT; Nanus DM
    Clin Cancer Res; 2001 May; 7(5):1370-7. PubMed ID: 11350908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.